![Rodger Novak](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rodger Novak
Fondateur chez
Xap Therapeutics Ltd
Profil
Rodger Novak a fondé CRISPR Therapeutics AG et Nabriva Therapeutics GmbH. Actuellement, le Dr Novak occupe le poste de président du conseil d'administration et de président de CRISPR Therapeutics AG. Dans le passé, il a occupé les postes de directeur mondial de la recherche et du développement dans le domaine des anti-infectieux chez Sanofi Pharma SA, de directeur des opérations de Nabriva Therapeutics GmbH, de directeur des affaires scientifiques et médicales de l'Institut de recherche sur les antibiotiques, de directeur adjoint de l'Institut de recherche sur les antibiotiques de Sandoz AG, de directeur adjoint de l'Institut de recherche sur les antibiotiques de Sandoz GmbH et de professeur de microbiologie au Vienna Biocenter. Rodger Novak a obtenu un doctorat de l'université Philipps de Marbourg.
Postes actifs de Rodger Novak
| Sociétés | Poste | Début |
|---|---|---|
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Private Equity Investor | 01/10/2020 |
ERS Genomics Ltd.
 ERS Genomics Ltd. BiotechnologyHealth Technology Develops biotechnology products | Directeur/Membre du Conseil | 01/01/2014 |
Airna, Inc.
 Airna, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of RNA editing therapeutics | Directeur/Membre du Conseil | - |
Xap Therapeutics Ltd
 Xap Therapeutics Ltd Pharmaceuticals: MajorHealth Technology Develops multi-modal therapies to treat complex diseases: cancer and autoimmunity | Fondateur | - |
Anciens postes connus de Rodger Novak
| Sociétés | Poste | Fin |
|---|---|---|
SR One Capital Management LP
 SR One Capital Management LP Investment ManagersFinance SR One invests in companies located in the United States and the United kingdom. The firm focuses on the biotechnology sector. It provides financing for early stage capital requirements. | Private Equity Investor | 01/01/2025 |
| CRISPR THERAPEUTICS AG | Directeur Général | 01/12/2017 |
Sanofi AG | Corporate Officer/Principal | 01/11/2013 |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Develops generic medicines and biosimilars | Corporate Officer/Principal | 01/12/2005 |
CRISPR Therapeutics, Inc.
 CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene based medicines for the treatment of human diseases | Fondateur | - |
Formation de Rodger Novak
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
31
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Finance |
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Develops generic medicines and biosimilars | Health Technology |
Antibiotic Research Institute
 Antibiotic Research Institute Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical research | Commercial Services |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research and development services | Health Technology |
Philipps University of Marburg
 Philipps University of Marburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sandoz GmbH
 Sandoz GmbH Pharmaceuticals: MajorHealth Technology Manufactures generic pharmaceuticals and biotechnological drugs | Health Technology |
Sanofi AG | |
CRISPR Therapeutics AG
 CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Vienna Biocenter
 Vienna Biocenter Miscellaneous Commercial ServicesCommercial Services Operates biology research center | Commercial Services |
ERS Genomics Ltd.
ERS Genomics Ltd. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
CRISPR Therapeutics, Inc.
CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene based medicines for the treatment of human diseases | Health Technology |
SR One Capital Management LP
SR One Capital Management LP Investment ManagersFinance SR One invests in companies located in the United States and the United kingdom. The firm focuses on the biotechnology sector. It provides financing for early stage capital requirements. | Finance |
Xap Therapeutics Ltd
Xap Therapeutics Ltd Pharmaceuticals: MajorHealth Technology Develops multi-modal therapies to treat complex diseases: cancer and autoimmunity | Health Technology |
Airna, Inc.
Airna, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of RNA editing therapeutics | Commercial Services |
